Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

TWiV 1054: Clinical update with Dr. Daniel Griffin

TWiV 1054: Clinical update with Dr. Daniel Griffin

FromThis Week in Virology


TWiV 1054: Clinical update with Dr. Daniel Griffin

FromThis Week in Virology

ratings:
Length:
42 minutes
Released:
Oct 21, 2023
Format:
Podcast episode

Description

In his weekly clinical update, Dr. Griffin discusses high Influenza incidence and disease severity among children and adolescents aged <18 years, neurologic effects of SARS-CoV-2 transmitted among dogs, effectiveness of monovalent mRNA vaccines against Omicron XBB infection in Singaporean children younger than 5 years, the effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions, incidence and impact of acute pericarditis in hospitalized patients with COVID‐19, serotonin reduction in post-acute sequelae of viral infection, prevalence and risk factors for long COVID and post-COVID-19 condition in Africa, safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with advanced chronic kidney disease and COVID-19, antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode High Influenza incidence and disease severity among children and adolescents aged <18 years (CDC) Neurologic effects of SARS-CoV-2 transmitted among dogs (EID) Effectiveness of mRNA vaccines against Omicron XBB infection in Singaporean children (JAMA) Effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions (ASHE) Incidence and impact of acute pericarditis in hospitalized patients with COVID‐19 (JAHA) Serotonin reduction in post-acute sequelae of viral infection (Cell) Prevalence and risk factors for long COVID and post-COVID-19 in Africa (The Lancet) Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with kidney disease and COVID-19 (CID) Antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1054 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
Released:
Oct 21, 2023
Format:
Podcast episode

Titles in the series (100)

This Week in Virology is a netcast about viruses - the kind that make you sick.